-
How Can We Have More Successful Rare Disease Trials?
By: Reverba Clinical Partnerships Team More than 300 million people around the world live with a rare disease—that is, a condition that affects fewer than 1 in 2,000. Although each…
-
Patient insights on trials: improving trust, the experience, and diversity.
By: Reverba Clinical Partnerships Team We have all made New Year’s resolutions – some we keep, and some never come to fruition. What are your goals as an organization? You…
-
Patient Engagement: What Matters Most in 2023. A retrospective by Cheryl Lubbert
By: Cheryl Lubbert Think about 2022 – what stands out to you the most? For me, it’s how often we heard that things were “returning to normal” after two years…
-
Reverba Celebrates 20 Years of Amplifying Patient Voices
– 20th Anniversary demonstrates Reverba has the staying power and adaptability to continue leading the way in patient engagement solutions for life sciences companies – SEATTLE – October 10, 2022…
-
It’s Our Anniversary: 20 Years, 20 Reasons to Believe
By: Cheryl Lubbert Today, we turn 20. Sixteen may be sweet, but twenty means so much more when you’re talking about the lifetime of a company. In an age of…
-
HBA Rising Star: Stephanie Hayes
By: Cheryl Lubbert As a pioneer in patient engagement, Reverba wouldn’t be where it is today without a talented team of individuals in roles spanning the organization. Every so often,…
-
Health Perspectives Group becomes Reverba
Entering the company’s 20th year, this new chapter represents the next level of transformativetech-enabled patient engagement for the biopharmaceutical industry – SEATTLE – November 10, 2021 – Health Perspectives Group,…
